Enhance your clinical practice by attending this dynamic conference exploring the intersection of conventional and integrative approaches to gastrointestinal health. Through expert-led presentations, we'll review some of the most commonly prescribed medications for GI disorders — including therapies for acid suppression, motility support, infection management, and inflammation control — while addressing challenges like long-term side effects and microbiome health. You'll also discover evidence-based herbal and lifestyle strategies that can complement or optimize pharmacologic treatments. Whether you're managing simple GI complaints or complex inflammatory conditions, this program offers practical insights to help you personalize patient care, minimize risks, and promote long-term gut wellness. Join colleagues and thought leaders for a fresh, integrative look at gastrointestinal pharmacotherapy!
12 PDA points to be applied forvia NCCAOM (National Certification Commission for Acupuncture and Oriental Medicine)
NUNM is accredited by the North American Naturopathic Continuing Education Accreditation Council (NANCEAC). This activity qualifies for 12.0 CEUs (specialty credits pending).
Webinar Details:
This fully online virtual event will be hosted through Zoom
Recordings of all conference presentations are provided for attendees at no additional cost
Recordings can be viewed for credit after the event if you do not attend live
Early Bird Deadlines:
11/28/2025: all prices listed below increase by $50
12/26/2025: all prices listed below increase by an additional $25
Saturday, January 10
9:00 - 10:30 AM
"Low Dose Naltrexone: Novel Approach to GI Disorders"
Leonard Weinstock, MD, FACG
10:30 - 11:00 AM
BREAK
11:00 - 12:30 PM
"TBA"
TBA
12:30 - 1:30 PM
LUNCH
1:30 - 3:00 PM
"Pharmacology for GI Infections"
Paul Anderson, ND
3:00 - 3:30 PM
BREAK
3:30 - 5:00 PM
"Trust Your Gut… and Customize It: Compounding for the GI"
Natalie Gustafson, RPh, PharmD
Sunday, January 11
9:00 - 10:30 AM
"Potassium-Competitive Acid Blockers: A Step Forward in the Treatment of Acid-Related Diseases"